KEYNOTE-689: what it means for locally advanced head and neck cancer
Dr. Ravindra Uppaluri, Dr. Dylan Roden, and Dr. Adam Luginbuhl discuss how the KEYNOTE-689 trial is transforming care for locally advanced head and neck cancer,...
Head And Neck
Latest Post
Implementation of Neoadjuvant Immunotherapy for head and neck cancer: Indications and patient selection
Dr. Adam Luginbuhl, Dr. Dylan Roden, and Dr. Ravindra Uppaluri explore how neoadjuvant immunotherapy is...
Neoadjuvant considerations in head and neck cancer
Dr. Adam Luginbuhl, Dr. Dylan Roden, and Dr. Ravindra Uppaluri explore the impact of Keynote-689...